Cardiovascular diseases (CVDs) continue to be the leading cause of death worldwide. Furthermore, presence of CVD increases the risk of developing comorbidities such as chronic kidney disease. Despite recent therapeutic advancements, an unmet need remains in the prevention and management of CVDs, particularly in patients with diabetes.